Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
Advanced Healthcare Materials|May 15, 2026
Functional Precision Oncology Approach Using Nanoliter Droplet Array for Drug Sensitivity Testing in Lung CancerMaryam Salarian, Vicky L Schiling, Thomas Muley, et al.
Scientific Reports|September 20, 2016
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patientsAnja Lisa Riediger, Steffen Dietz, Uwe Schirmer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56Katharina Kriegsmann, Christiane Zgorzelski, Daniel Kazdal, et al.
Cancers|October 16, 2024
Impact of T Cell Ratios on Survival in Pleural Mesothelioma: Insights from Tumor Microenvironment AnalysisLaura V Klotz, Andreas Weigert, Florian Eichhorn, et al.
Lung Cancer (Amsterdam, Netherlands)|October 25, 2006
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphismsOdilia Popanda, Lutz Edler, Peter Waas, et al.
Histopathology|December 16, 2017
Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomasMark Kriegsmann, Alexander Harms, Rémi Longuespée, et al.
Cancer & Metabolism|June 16, 2025
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesisAnn-Kathrin Daum, Lisa Schlicker, Marc A Schneider, et al.
Oncotarget|October 8, 2016
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesotheliomaMarc A Schneider, Thomas Muley, Nicolas C Kahn, et al.
Cancers|April 30, 2021
Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center AnalysisFlorian Eichhorn, Mark Kriegsmann, Laura V Klotz, et al.
The European Respiratory Journal|November 15, 2011
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapyArne Warth, Stephan Macher-Goeppinger, Thomas Muley, et al.
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Advanced Healthcare Materials|May 15, 2026
Functional Precision Oncology Approach Using Nanoliter Droplet Array for Drug Sensitivity Testing in Lung CancerMaryam Salarian, Vicky L Schiling, Thomas Muley, et al.
Scientific Reports|September 20, 2016
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patientsAnja Lisa Riediger, Steffen Dietz, Uwe Schirmer, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56Katharina Kriegsmann, Christiane Zgorzelski, Daniel Kazdal, et al.
Cancers|October 16, 2024
Impact of T Cell Ratios on Survival in Pleural Mesothelioma: Insights from Tumor Microenvironment AnalysisLaura V Klotz, Andreas Weigert, Florian Eichhorn, et al.
Lung Cancer (Amsterdam, Netherlands)|October 25, 2006
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphismsOdilia Popanda, Lutz Edler, Peter Waas, et al.
Histopathology|December 16, 2017
Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomasMark Kriegsmann, Alexander Harms, Rémi Longuespée, et al.
Cancer & Metabolism|June 16, 2025
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesisAnn-Kathrin Daum, Lisa Schlicker, Marc A Schneider, et al.
Oncotarget|October 8, 2016
Glycodelin is a potential novel follow-up biomarker for malignant pleural mesotheliomaMarc A Schneider, Thomas Muley, Nicolas C Kahn, et al.
Cancers|April 30, 2021
Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center AnalysisFlorian Eichhorn, Mark Kriegsmann, Laura V Klotz, et al.
The European Respiratory Journal|November 15, 2011
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapyArne Warth, Stephan Macher-Goeppinger, Thomas Muley, et al.
Pageof 23